Back to Article
Treatment by Ceftolozane/Tazobactam for <i>Pseudomonas </i><i>Aeruginosa</i><i> </i>Pneumonia Patients with or without Bacteremia
Global Journal of Medical Case Reports
| Vol 3, Issue 1
Table 2. Antibiotic susceptibilities for the isolated Pseudomonasaeruginosa of Case 2
| Day 0 | Day 7 | ||||
| MIC | S/I/R | MIC | S/I/R | ||
| AZT | 8 | S | 16 | I | |
| PIPC | 4 | S | >64 | R | |
| PIPC/TAZ | ≦4 | S | >64 | R | |
| IPM | 1 | S | 2 | S | |
| MEPM | 0.25 | S | 0.5 | S | |
| CAZ | 4 | S | >16 | R | |
| CFPM | 2 | S | 16 | I | |
| CTLZ/TAZ | ≦1/4 | S | ≦2/4 | S | |
| AMK | ≦4 | S | ≦4 | S | |
| GM | ≦2 | S | ≦2 | S | |
| MINO | >8 | R | >8 | R | |
| LVFX | 1 | S | 1 | S | |
| CPFX | 0.25 | S | 0.25 | S | |
| ST | 80 | R | 80 | R | |
Abbreviations: MIC; minimum inhibitory concentration, S/I/R; susceptible/intermediate/resistant, AZT; aztreonam, PIPC; piperacillin, PIPC/TAZ; piperacillin/tazobactam, CAZ; ceftazidim, CFPM; cefepime, CTLZ/TAZ; ceftolozane/tazobactam, IPM; imipenem, MEPM; meropenem, MINO; minocycline LVFX; levofloxacin, CPFX; ciprofloxacin, AMK; amikacin, GM; gentamycin, ST; sulfamethoxazole/trimethoprim.